Press Releases

Share

Aa-+

  • Colchicine reduces the risk of COVID-19-related complications

    January 23, 2021

    Positive results from COLCORONA trial show that colchicine is the only effective oral medication for treating non-hospitalized patients

    Read more

  • New data supports development of colchicine for the prevention of acute respiratory distress syndrome

    December 7, 2020

    This syndrome can develop in patients with COVID-19 if the virus enters the respiratory tract and damages the lungs

    The Montreal Heart Institute (MHI) has announced that colchicine, a widely available low-cost drug, reduces acute lung injury (ALI), acute respiratory distress syndrome (ARDS) and respiratory failure in pre-clinical models1. The article reporting these results was published yesterday by the Public Library of Science ONE (PLOS ONE) 1.

    Read more

  • Colchicine shows promise as a treatment for at-home COVID-19 patients

    November 29, 2020

    Recruitment of participants in the COLCORONA phase 3 study likely to end in 2020

    The Montreal Heart Institute (MHI) today announced that the COLCORONA clinical trial will continue to recruit non-hospitalized adult patients with COVID-19 as recommended by the independent data monitoring committee (DMC), following a second interim analysis.

    Read more

  • Early Invasive Intervention for Atrial Fibrillation may Improve Patient Outcomes and Provide a Better Quality of Life

    November 16, 2020

    Doctors from the Montreal Heart Institute (MHI) presented new data today at the American Heart Association Late-Breaking Scientific Sessions. Simultaneously published in the New England Journal of Medicine, the data shows that catheter ablation as first-line treatment may be better than antiarrhythmic drugs in preventing the recurrence of abnormal heart rhythm (atrial tachyarrhythmia, atrial fibrillation), and improve patient well-being.

    Read more

  • CQDM funds the development of a novel artificial intelligence tool for cardiovascular clinical trials

    November 5, 2020

    A collaboration between Perceiv AI, DalCor Pharmaceuticals and the Montreal Heart Institute

    The CQDM is pleased to announce the launch of a $600,000 collaborative project in biopharma and artificial intelligence (AI) to develop an AI-driven precision medicine tool.

    Read more

  • Common hormone could provide the answer to treating atrial fibrillation

    November 5, 2020

    Researchers from University of Montreal, Oxford University, Baylor College of Medicine and the University of Melbourne make potential game-changing discovery on calcitonin

    New research published today in Nature1 shows that calcitonin, a well-recognized thyroid hormone that helps regulate bone mass and collagen production, is also produced by cells in the heart. This discovery could hold the key to developing new treatments for people with atrial fibrillation (AF), a common and quite problematic heart rhythm disorder.

    Read more

  • The Montreal Heart Institute stands out at the prestigious European Society of Cardiology congress

    August 31, 2020

    During the prestigious virtual congress of the European Society of Cardiology (ESC), researchers from the Montreal Heart Institute (MHI) presented recent data regarding the impact of colchicine on cardiovascular disease.

     

    These three new analyses from the COLCOT (COLchicine Cardiovascular Outcomes Trial) clinical trial confirm the benefits of colchicine, an inexpensive and already available drug, to prevent cardiovascular events in patients who survived a heart attack, also known as myocardial infarction (MI).

     

    Read more

  • Montreal Heart Institute announces COLCORONA trial in patients with COVID-19 passes futility test in interim analysis

    June 30, 2020

    Colchicine, a common drug to treat gout, is being evaluated as a potential treatment in the fight against coronavirus

    Read more

  • Ms. Sonia Heppell receives the Dr. Denis Roy Award for Excellence in Nursing

    June 4, 2020

    The Montreal Heart Institute (MHI) is proud to announce that Ms. Sonia Heppell has received the Dr. Denis Roy Award for Excellence in Nursing. This new award, which was made possible thanks to Dr. Denis Roy and donors of the Montreal Heart Institute Foundation (MHIF), was created to honour a member of the nursing staff who has stood out thanks to the excellence of their work. More specifically, the award acknowledges initiatives that improve practices and the care provided to patients as well as those that encourage and recognize the exceptional work of the MHI’s nursing staff.

    Read more

  • 300 health workers sought for COVID-19 burnout study

    May 20, 2020

    Factors associated with burnout in Quebec health care workers during the COVID-19
    pandemic

    The Montreal Heart Institute (MHI) is currently looking for 300 health
    professionals and workers in Quebec to participate in a unique study on the " Factors associated
    with burnout in Quebec health care workers during the COVID-19 pandemic: an observational
    study”.

    Read more

Pages